US OptionsDetailed Quotes

ASTS241213C29000

Watchlist

0.04
+0.01+33.33%

15min DelayClose Dec 13 16:00 ET

0.05High0.01Low

AST SpaceMobile Stock Discussion

10xStockPicks

8 minutes ago

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...

Patience3to6Lumen

5 hours ago

$Tonix Pharmaceuticals (TNXP.US)$ $AST SpaceMobile (ASTS.US)$
16 Investment Approaches with Updated Examples (December 2024)
1. Buy Companies Before Big News Breaks
• Examples:
• Tonix Pharmaceuticals (TNXP)
• AST SpaceMobile (ASTS)
2. Buy Established Companies on Positive Quarterly Results
• Examples:
• Tesla (TSLA)
• Meta Platforms (META)
• Broadcom (AVGO)
3. Buy Companies with Imminent Profitability
• Examples:
• SoundHound AI (SOUN)
• AeroVironment (AVAV)
• Kratos Defense & Security (KTOS)
•...

10xStockPicks

18 hours ago

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...